| WY52 Stock | | | EUR 0.16 0.04 33.33% |
CFO
Nathan DeBacker is Chief Financial Officer of CREMECOMTRSBI DL 001 since 2019.
| Age | 39 |
| Tenure | 5 years |
| Phone | 972-349-3200 |
| Web | http://www.cimcommercial.com |
CREMECOMTRSBI Management Efficiency
The company has return on total asset
(ROA) of
0.0151 % which means that it generated a profit of $0.0151 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.014 %, meaning that it generated $0.014 on every $100 dollars invested by stockholders. CREMECOMTRSBI's management efficiency ratios could be used to measure how well CREMECOMTRSBI manages its routine affairs as well as how well it operates its assets and liabilities.
CREMECOMTRSBI DL 001 has accumulated 260.72
M in total debt with debt to equity ratio
(D/E) of 0.64, which is about average as compared to similar companies. CREMECOMTRSBI DL 001 has a current ratio of 7.13, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist CREMECOMTRSBI until it has trouble settling it off, either with new capital or with free cash flow. So, CREMECOMTRSBI's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CREMECOMTRSBI DL 001 sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CREMECOMTRSBI to invest in growth at high rates of return. When we think about CREMECOMTRSBI's use of debt, we should always consider it together with cash and equity.
CIM Commercial is a real estate investment trust that primarily acquires, owns, and operates Class A and creative office assets in vibrant and improving metropolitan communities throughout the United States . CIM Commercial is operated by affiliates of CIM Group, L.P., a vertically-integrated owner and operator of real assets with multi-disciplinary expertise and in-house research, acquisition, credit analysis, development, finance, leasing, and onsite property management capabilities. CIM COMM operates under REITOffice classification in Germany and is traded on Frankfurt Stock Exchange. It employs 4 people. CREMECOMTRSBI DL 001 (WY52) is traded on Frankfurt Exchange in Germany and employs 5 people.
Management Performance
CREMECOMTRSBI DL 001 Leadership Team
Elected by the shareholders, the CREMECOMTRSBI's board of directors comprises two types of representatives: CREMECOMTRSBI inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CREMECOMTRSBI. The board's role is to monitor CREMECOMTRSBI's management team and ensure that shareholders' interests are well served. CREMECOMTRSBI's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CREMECOMTRSBI's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jan Salit, President Secretary | |
| Frank Golay, Independent Director | |
| Avi Shemesh, Director | |
| Avraham Shemesh, Director | |
| David Thompson, Chief Executive Officer | |
| Robert Cresci, Independent Director | |
| Kelly Eppich, Independent Director | |
| Douglas Bech, Independent Director | |
| Richard Ressler, Chairman of the Board | |
| Shaul Kuba, Director | |
| Nathan DeBacker, Chief Financial Officer | |
CREMECOMTRSBI Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CREMECOMTRSBI a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in CREMECOMTRSBI Stock
CREMECOMTRSBI financial ratios help investors to determine whether CREMECOMTRSBI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CREMECOMTRSBI with respect to the benefits of owning CREMECOMTRSBI security.